Stem cell binding to the endothelium during extravasation
Prof G Cossu, Prof N Tirelli
Applications accepted all year round
In a previous clinical trial carried out by the team (Cossu et al. 2015), HLA-matched, donor mesoangioblasts (pericyte-derived myogenic progenitors) were infused intra-arterially to patients with Duchenne muscular dystrophy.
Dissecting the Determinants of Response to Checkpoint Inhibitors
Dr B Fairfax, Prof M Middleton
11 January 2019
Cancer treatment is being revolutionised by checkpoint inhibitor immunotherapy (CKI). In melanoma, where there is limited role for radiotherapy or chemotherapy, CKI forms the frontline treatment.